Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone SR gastro-resistant capsules for functional constipation
2009-011853-42Phase 2Completed
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional constipation (FC) and constipation comparing Naloxone SR + usual laxatives with Placebo + usual laxatives (2 arms). Primary endpoint: Primary responder rate during Period 2 (weeks 3–6). Started Mar 2010; status: completed.
02
Drugs
naloxone
03
Conditions
functional constipation (FC)constipation
Beyond the preview
Go deeper on 2009-011853-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011853-42.